Wild-type (senile) amyloidosis surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Surgery== | ==Surgery== | ||
*Surgery is not the mainstay of therapy for wild-type (senile) amyloidosis. | *Surgery is not the mainstay of therapy for wild-type (senile) amyloidosis. | ||
*Left ventricular assist devices (LVAD) implantation can be considered but a review of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database is necessary to better evaluate the outcomes of LVAD implantation. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 20:08, 19 December 2019
Wild-type (senile) amyloidosis Microchapters |
Differentiating Wild-type (senile) amyloidosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Wild-type (senile) amyloidosis surgery On the Web |
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis surgery |
Risk calculators and risk factors for Wild-type (senile) amyloidosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Surgery
- Surgery is not the mainstay of therapy for wild-type (senile) amyloidosis.
- Left ventricular assist devices (LVAD) implantation can be considered but a review of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database is necessary to better evaluate the outcomes of LVAD implantation.